Search

everythinglearnresearchcommunity

for

Search:↓

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Erectile dysfunction in young men is caused by both mental and physical factors and needs a personalized treatment approach.

Phytoandrogens from plants may help treat low testosterone naturally.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

New treatments for male hypogonadism are effective and should be personalized.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

No definitive link between finasteride and male breast cancer, but further research is needed.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.